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Keratinocyte Apoptosis in Epidermal Development and 
Disease
Deepak Raj1.2, Douglas E. Brash3,4 and Douglas Grossman1,2,5
Keratinocyte (KC) apoptosis plays a critical role in regulating epidermal development and restraining carcinogenesis. 
Apoptosis balances proliferation to maintain epidermal thickness, contributes to stratum corneum formation and may 
eliminate pre-malignant cells. Apart from the normal developmental program, KC apoptosis can be triggered by UV light 
and other stimuli. Dysfunctional apoptosis occurs in some skin diseases, such as psoriasis and skin cancer. Here we review 
the current state of knowledge of KC apoptosis, with particular focus on apoptotic signaling pathways and molecular 
mechanisms of apoptosis control, and discuss new insights into the complex role of apoptosis in skin carcinogenesis that 
are emerging from mouse models.
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Perhaps the greatest irony in biology 
is that life depends on death — pro-
grammed cell death, that is. Cell 
elimination by apoptosis is essential 
for organ sculpting in development, 
normal tissue turnover, and efficient 
removal of infected or damaged cells 
and autoreactive lymphocytes. It is 
estimated that each day, in an average 
adult, over 50 billion cells undergo 
apoptosis (Reed, 1999). It has been only 
30 years since Olson and Everett (1975) 
first described apoptosis in normal skin, 
shortly after the term was coined in the 
medical literature in 1972 (Kerr et al., 
1972). In the following years, Horvitz, 
Sulston, and Brenner discovered sev-
eral Caenorhabditis elegans death (ced) 
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Editor's Note
An organism's or an organ system's ability to grow 
and renew itself requires both cell proliferation and 
regulated cell death. A regulated form of cell death has 
been noted since at least the mid-1800s, and in 1964 
Lockshin and Williams coined the term “programmed 
cell death” to describe developmental events in insect 
larvae (J Insect Physiol 10:643–649, 1964). In 1972 Kerr, 
Wyllie, and Currie used the term apoptosis to describe 
morphologic features of dying cells observed in a variety 
of organs and conditions (Br J Cancer 26:239–257, 1972). 
Early in the story of apoptosis, Kerr and Searle found 
the prominent shrinkage necrosis of the cells that is 
characteristic of apoptosis in basal cell carcinomas (J 
Pathol 107:41–44, 1972). In 2002 Brenner, Horvitz, and 
Sulston were awarded the Nobel Prize in Medicine 
for their discoveries concerning “genetic regulation 
of organ development and programmed cell death.” 
Because skin and hair constantly renew themselves and 
are subject to environmental damage, programmed cell 
death is critical to their normal function. In this issue 
of the Journal, the Perspectives series continues with 
two articles on apoptosis in keratinocytes and in the 
hair follicle. Raj, Brash, and Grossman offer insight into 
the process of apoptosis in development and diseases 
of the keratinocyte. They provide a special focus on 
the regulation of apoptosis in the skin and its potential 
application for our understanding of carcinogenesis in 
the skin. Botchkareva, Ahluwalia, and Shander extend the 
focus to include the hair follicle. Understanding how the 
process of apoptosis applies to the hair cycle provides 
great opportunity for future investigations regarding 
the pathogenesis of many hair disorders as well as the 
hair loss associated with aging. These Perspectives on 
apoptosis will provide a platform for further investigation 
of this exciting and important area of the biology of skin 
and skin diseases.  Russell P. Hall 
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genes and established that apoptosis 
represents a genetically encoded path-
way in worms, in work for which they 
were recently awarded a Nobel Prize. 
The discovery of bcl-2 translocation in 
follicular lymphoma in 1984 eventual-
ly led to the first link between apoptosis 
and cancer. In the past decade, studies 
in mammalian cells have character-
ized multiple interconnected apoptotic 
pathways and identified a multitude of 
additional regulatory factors. A review 
of our current state of knowledge of 
keratinocyte (KC) apoptosis, focusing 
on apoptotic signaling pathways and 
molecular mechanisms of apoptosis 
control, is particularly timely because 
it has been 12 years since the topic of 
apoptosis in epidermal development 
and disease was last reviewed in the 
Journal (Haake and Polakowska, 1993).
In no other organ system does apop-
tosis play so many vital roles as in the 
skin. Apoptotic cell death is critical for 
balancing of KC proliferation as well as 
for formation of the stratum corneum. 
Apoptosis also represents an important 
cancer defense mechanism, as KCs that 
may have accumulated mutations or 
sustained other genetic damage as a 
consequence of exposure to UV radia-
tion or oxidative damage are eliminat-
ed by apoptosis. The development of 
genetic mouse models in which apop-
totic regulatory molecules are deleted 
or overexpressed in the skin has vali-
dated many of these functions of apop-
tosis. Here, we will first summarize 
the basic components of the cell death 
machinery and their integrated function 
in apoptotic pathways in KCs. Next, 
we will describe KC apoptosis in vivo 
and consider the evidence that KC cell 
death in epidermal development repre-
sents apoptosis rather than an alternate 
form of cell death. The essential role 
of apoptosis in maintaining epider-
mal structure and homeostasis will be 
reviewed, as well as its dysregulation in 
skin disease and skin cancer. Finally, we 
will discuss how KC apoptosis serves 
as a cancer-preventive mechanism by 
eliminating potentially pre-malignant 
cells and may modulate early steps in 
skin carcinogenesis.
General Pathways and Mechanisms of 
Apoptotic Control
Early work on apoptosis in worms elu-
cidated a sequential genetic pathway 
consisting of an activator molecule 
(EGL-1), an inhibitor molecule (ced-9), 
an adapter molecule (ced-4), and an 
effector molecule (ced-3). This para-
digm of activators, inhibitors, adapt-
ers, and effectors is recapitulated in 
multiple apoptotic pathways in mam-
malian cells. Apoptotic pathways and 
regulators potentially important in KCs 
are depicted in Figure 1, and reviewed 
extensively elsewhere (Reed, 1999). 
Cells respond to environmental, extra-
cellular, and internal death signals 
through multiple sensors that coordi-
nate and integrate apoptotic respon-
ses. The ‘extrinsic’ pathway is stimu-
lated by binding of Fas ligand (Fas-L), 
tumor necrosis factor (TNF), or related 
cytokines to extracellular membrane 
‘death receptors’ that recruit adapter 
molecules and lead to activation of 
caspase-8. Caspases (ced-3 homo-
logues; cysteine aspartic acid-specific 
proteases) are constitutive proenzymes 
that autoactivate or are activated upon 
cleavage by other caspases, resulting 
in a proteolytic cascade. Some cells 
express FLIP, an inhibitor of caspase-8 
that blocks death receptor signaling. 
The ‘intrinsic’ pathway, triggered by 
most cytotoxic drugs and DNA dam-
age, involves mitochondrial release of 
cytochrome c, which combines with 
the cofactor Apaf-1 (ced-4 homologue) 
in the formation of an activated cas-
pase-9 ‘apoptosome.’ Mitochondria 
may also promote apoptosis through 
release of Smac/DIABLO, which blocks 
inhibitor of apoptosis (IAP) proteins 
that function as caspase inhibitors, and 
apoptosis-inducing factor (AIF), which 
translocates to the nucleus and medi-
ates caspase-independent apoptosis. 
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Figure 1. Apoptotic pathways in keratinocytes. The extrinsic pathway is stimulated by UVB or binding of 
Fas ligand, tumor necrosis factor, or other cytokines to death receptors that results in activation of caspase-
8. The intrinsic pathway is also stimulated by UVB, as well as various cytotoxic drugs, and is linked to 
DNA damage responses. It involves mitochondrial depolarization and release of multiple proapoptotic 
factors. In addition, UVB results in formation of DNA photo-products and initiation of DNA damage 
responses. Mitochondrial content release may directly result from these stimuli or may occur indirectly 
as part of the DNA damage response. Cytochrome c promotes activation of caspase-9, Smac inhibits 
inhibitor of apoptosis (IAP) caspase inhibitors, and apoptosis-inducing factor (AIF) translocates to the 
nucleus and mediates caspase-independent apoptosis. The extrinsic and intrinsic pathways are potentially 
linked by Bid, which is cleaved by caspase-8, and the activated fragment (tBid) causes mitochondrial 
content release. Activation of upstream caspases (caspase-8 or -9) leads to activation of downstream 
caspases (caspase-3 or -7), resulting in cleavage of intracellular substrates, cellular condensation, and 
nuclear fragmentation. Apoptotic inhibitors include caspase inhibitors (FLIP, IAP proteins) and the Bcl-2 
family proteins Bcl-2 and Bcl-xL that prevent mitochondrial membrane permeability.
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is regulated by Bcl-2 family proteins 
that form homodimers and heterodi-
mers that control mitochondrial mem-
brane permeability. Some Bcl-2 family 
proteins (Bcl-2, ced-9 homologue, and 
Bcl-xL) may block apoptosis whereas 
others (Bax, Bak, and Bid) promote 
apoptosis by interfering with these 
interactions. The p53 tumor suppres-
sor promotes apoptosis through both 
transcriptional and non-transcrip-
tional mechanisms, as detailed below. 
The extrinsic and intrinsic pathways 
are potentially linked in an amplifica-
tion loop by Bid, which is cleaved by 
caspase-8, and the resulting fragment 
(tBid) translocates to the mitochondria 
and triggers cytochrome c release and 
activation of caspase-9. Activation of 
either of these upstream caspases leads 
to activation of terminal caspase-3 and 
caspase-7, which dismantle cells by 
cleaving proteins involved in nuclear 
membrane and cytoskeletal structure, 
DNA repair, and replication systems.
The Apoptotic Program in Keratinocytes
Apoptotic stimulation in keratinocytes.
It is important to note that the character-
ization of many of these pathways and 
regulatory networks — indeed, much 
of our mechanistic knowledge of apop-
tosis in general — comes largely from 
in vitro studies in HeLa cells or other 
cell lines. Similarly, many mechanistic 
studies on KC apoptosis have used the 
human HaCaT cell line (which harbors 
two mutant p53 alleles) as a model for 
normal KCs. We have actually found 
HaCaT cells to be more susceptible 
to apoptosis than normal KCs in vitro 
(Bowen et al., 2003), possibly because 
of aberrant signaling pathways result-
ing from long-term culture (Chaturvedi 
et al., 2001). In addition, most studies 
examining apoptosis in normal KCs 
have been performed on cultured cells 
in the presence of exogenous growth 
factors. Apoptotic responses in vivo, 
however, necessarily occur in distinct 
cellular and tissue contexts. Therefore, 
after a summary of observations made 
in cultured HaCaT cells and KCs, the 
remainder of this review will focus on 
studies using epidermal constructs, 
in situ detection methods, and animal 
models that may be most relevant to KC 
apoptosis in vivo.
A variety of agents have been shown 
to induce KC apoptosis in vitro. The most 
intensively studied, and perhaps most 
physiologically relevant, is UVB (290–
320 nm). Although UVB induces expres-
sion of multiple genes in KCs, execution 
of the apoptotic program requires not de 
novo transcription but rather activation 
of pre-synthesized proteins. Multiple 
studies have shown that doses ranging 
from 200 to 700 J/m2 induce KC apop-
tosis over a 24- to 48-hour period that is 
preceded by mitochondrial depolariza-
tion, release of cytochrome c, and acti-
vation of multiple caspases (caspase-3, 
-8, and -9). UVB triggers multimeriza-
tion of Fas death receptors, leading to 
activation of caspase-8 (Takahashi et al., 
2001a), and caspase-8-mediated cleav-
age of Bid is important for amplifica-
tion of the apoptotic response (Assefa 
et al., 2000). In most KC-based systems, 
UVB-induced apoptosis appears to be 
caspase-dependent, as responses can 
be blocked with caspase inhibitors, 
although induction of apoptosis-induc-
ing factor-mediated caspase-indepen-
dent apoptosis has not been rigorously 
examined. Although caspase-8 and cas-
pase-9 appear to be concomitantly acti-
vated in response to UVB, Sitailo et al. 
(2002) showed that upstream caspase-9 
is critical for these responses, by block-
ing with specific peptide or dominant-
negative caspase-9 inhibitors. Consistent 
with this observation, UVB-induced KC 
apoptosis can be blocked by transfection 
of Bcl-2 (Takahashi et al., 2001b). One 
target of activated terminal caspase-3 is 
protein kinase Cδ, which, upon cleav-
age, translocates to the mitochondria. 
Blocking protein kinase Cδ activation 
with a kinase-inactive catalytic domain 
(Denning et al., 2002) or caspase-resis-
tant mutant (D’Costa and Denning, 
2005) prevents UVB-induced KC apop-
tosis. Recent studies by Denning and 
colleagues (L Sitailo, SS Tibudan and 
MF Denning, 2005, J Invest Dermatol 
124:A129) indicate that activated pro-
tein kinase Cδ phosphorylates the Bcl-2 
homologue Mcl-1 in vitro and disrupts 
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Figure 2. Survival (antiapoptotic) pathways in keratinocytes. The two primary survival pathways 
involve activation of a mitogen-activated protein kinase (MAPK) cascade and activation of Akt. 
Integrin-mediated interactions with matrix proteins, particularly laminin 5, as well as signaling through 
epidermal growth factor receptor (EGFR), lead to sequential phosphorylation and activation of MAPKs. 
The precise mechanism(s) by which activated MAPK kinases (MEKs) promote cell survival is not known 
(dotted arrows). Signaling by epidermal growth factor (EGF) or hepatocyte growth factor (HGF) may 
also stimulate a second survival pathway involving phosphatidylinositol 3-kinase (PI3K), leading to 
phosphorylation and activation of Akt. Activated Akt promotes survival by activating the transcriptional 
regulator NF-κB and counteracts apoptosis by phosphorylating and inhibiting Bad and caspase-9. 
Caspase-9 is also subject to inhibition by IAP proteins. Finally, signaling by nerve growth factor (NGF) 
stabilizes levels of the antiapoptotic proteins Bcl-2 and Bcl-xL. ERK, extracellular signal-regulated kinase.
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its interaction with Bax in HaCaT cells. 
Early apoptotic signaling by UVB in KCs 
stimulates phosphorylation and stabili-
zation of the p38 mitogen-activated pro-
tein kinase (MAPK), which occur within 
2 hours of UVB exposure and precedes 
caspase activation (Shimizu et al., 1999). 
The function of various MAPK pathways 
in KCs has been previously reviewed 
by Eckert and colleagues (Eckert et al., 
2002). Inhibition of p38 MAPK activa-
tion prevents UVB-induced apoptosis, 
translocation of Bax to mitochondria, 
and cytochrome c release (Van Laethem 
et al., 2004). Lipid peroxidation and 
generation of oxidative radicals occur 
in KCs after UVB exposure (Carini et al., 
2000), and antioxidants may be protec-
tive (Kulms et al., 2002; Mu et al., 2003). 
Oxidative stress may directly activate 
p38 MAPK (Peus et al., 1999). As noted 
below, UVB-induced KC apoptosis in 
vivo involves both membrane-based sig-
naling and DNA damage. Finally, UVB 
can activate apoptotic pathways through 
induction of ceramide synthase and de 
novo ceramide synthesis (Uchida et al., 
2003).
Other UV wavelengths may also 
induce KC apoptosis in vitro, with 
apoptotic potency corresponding to 
increasing energy or decreasing wave-
length (Godar, 1999). Although UVC 
(100–290 nm) damages cellular DNA 
and is a more potent apoptotic stimu-
lus than UVB, it is largely absorbed in 
the atmosphere and does not reach the 
Earth’s surface. On the other hand, UVA 
(320–400 nm), which is less potent 
than UVB, appears to trigger apopto-
sis through oxidative damage (Fu et 
al., 2000). In addition to UV radiation, 
other apoptotic stimuli reported for 
KCs include the death receptor agonist 
TNF-related apoptosis-inducing ligand 
(TRAIL), rapid detachment (anoikis), 
growth factor deprivation, ceramide, 
cytotoxic drugs, 1,25-dihydroxyvita-
min D3, and transforming growth fac-
tor β1 (Benassi et al., 1997). Apoptosis 
induced by these agents generally 
involves activation of caspases and 
mitochondrial pathways, but the mech-
anisms are less well characterized than 
those involving UVB.
The majority of in vitro studies on 
KC apoptosis have been performed on 
human KCs. Recently, Chaturvedi and 
colleagues (Chaturvedi et al., 2004) 
compared apoptotic responses in cul-
tured human versus mouse KCs and 
reported that human KCs were more 
susceptible to UV- and drug-induced 
apoptosis. The relative apoptotic resis-
tance of mouse KCs was associated 
with decreased constitutive levels of 
p53 and increased expression of kera-
tin 1, an early marker of KC differentia-
tion. Although further determinants of 
this differential apoptotic susceptibility 
remain to be defined, these experiments 
suggest that mouse KCs maintained in 
vitro may exist in a more differentiated 
state and be less prone to p53-depen-
dent apoptosis. Nevertheless, p53-
dependent apoptosis of mouse KCs in 
vivo can readily be stimulated by UVB, 
as detailed below.
Antiapoptotic forces in keratinocytes. 
As is discussed above, the primary KC 
signaling pathway leading to cell death 
is activation of p38 MAPK, followed by 
mitochondrial depolarization and cas-
pase activation. This cell death pathway 
is promoted by p53 and Bax, which are 
minimally expressed in proliferating 
KCs (Bowen et al., 2003). On the other 
hand, this pathway may be antagonized 
in normal KCs through expression 
of multiple antiapoptotic regulators 
including Bcl-xL, FLIP, and various IAP 
molecules (c-IAP1, c-IAP2, XIAP, and 
Livin) (Bowen et al., 2003). Two nota-
ble cell survival pathways have been 
partially characterized in KCs. The first 
is a MAPK pathway (Figure 2) triggered 
by epidermal growth factor (EGF) and 
phosphorylation of epidermal growth 
factor receptor (EGFR). Whereas EGF 
can protect KCs against UVB-induced 
apoptosis, EGFR inhibitors enhance 
UVB-induced apoptosis (Peus et al., 
2000). Signaling through EGFR stimu-
lates a MAPK cascade that results in 
sequential phosphorylation and acti-
vation of MAPK kinases (MEKs) and 
extracellular signal-regulated kinases 
(ERKs). The mechanism by which acti-
vated ERKs promote cell survival in 
Cell survival
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Figure 3. Apoptotic balance in keratinocytes is mediated by multiple factors at multiple levels. 
Predominance of cell survival factors is evident in psoriasis, skin cancer, and hyperkeratotic diseases, 
whereas excessive cell death is characteristic of other diseases, including sunburn, toxic epidermal 
necrolysis (TEN), and graft-versus-host disease (GVHD). PKCδ, protein kinase Cδ.
D Raj et al.
Epidermal apoptosis
 www.jidonline.org 247
KCs has not been clearly elucidated. 
Signaling by EGF may also stimulate 
a second survival pathway involving 
phosphatidylinositol 3-kinase-medi-
ated activation of the serine/threonine 
kinase Akt (protein kinase B; Figure 2). 
In other cell types, Akt is activated by 
growth factors and promotes cell sur-
vival directly by phosphorylating (and 
inactivating) Bad and caspase-9 (Datta 
et al., 1999). Given the important role 
of caspase-9 in KC apoptosis, noted 
above, it is not surprising that Akt is a 
potent KC survival factor (Wang et al., 
2003). Akt also promotes survival in 
KCs by activating NF-κB, a transcription 
factor that is repressed by interaction 
with κB inhibitor (IκB). The role of NF-
κB in KC survival has been previously 
reviewed in the Journal by Nickoloff 
and colleagues (Nickoloff et al., 2002), 
who have shown that inhibition of NF-
κB using proteasome or IκB subunit 
inhibitors increases KC susceptibility to 
apoptosis. Activation of NF-κB through 
Akt signaling may promote KC survival 
by modulating expression of IAPs or 
TRAF death receptor adapters, as has 
been shown in other cell types.
Finally, in discussing cell death and 
survival pathways in KCs, it is impor-
tant to note that apoptotic stimuli may 
activate multiple pathways simultane-
ously. For example, several studies have 
demonstrated that UVB and TNF-α can 
activate the p38 MAPK death pathway 
and the MEK/ERK and Akt/NF-κB sur-
vival pathways (Nickoloff et al., 2002). 
Products of the MAPK pathways may 
intersect via a p38 MAPK/ERK complex 
that translocates to the nucleus in KCs 
in response to protein kinase Cδ acti-
vation (Efimova et al., 2004). Thus KCs 
must coordinate a delicate balance 
of many antiapoptotic and proapop-
totic forces in responding to extracel-
lular stimuli, shifting their equilibrium 
toward cell survival or cell death when 
one pathway predominates (Figure 3).
Most cell types are more susceptible 
to apoptosis in vitro than in vivo, and 
KCs are no exception. For example, 
lower doses of UVB are required to 
induce KC apoptosis in cultured cells 
compared with normal skin. Multiple 
survival signals present in tissues are 
likely to account for this increased KC 
resistance to apoptosis in vivo. Many 
of these are derived from interaction 
with extracellular matrix proteins. 
Laminin 5 is the primary ligand for epi-
dermal KC adhesion, binding to the 
α3β1 and α6β4 integrins on KCs. Using 
KCs derived from α3 knockout mice, 
Manohar et al. (Manohar et al., 2004) 
showed that laminin 5 binding of α3β1, 
and to a lesser extent α6β4, promotes 
KC cell survival through activation of 
a MEK/ERK signaling pathway. This 
survival pathway can also be activated 
through EGFR, protecting KCs against 
anoikis (Jost et al., 2001). In addition 
to EGF, other growth factors constitute 
a second class of survival signals that 
may potentially contribute to apoptosis 
resistance in vivo through Akt. Nerve 
growth factor and hepatocyte growth 
(scatter) factor protect KCs against UVB-
induced apoptosis by maintaining lev-
els of Bcl-2 and Bcl-xL (Marconi et al., 
1999) and by activating Akt (Mildner et 
al., 2002), respectively. Nuclear peroxi-
some proliferator-activated receptors 
in KCs can also promote Akt signaling 
through transcriptional effects (Di-Poi 
et al., 2002). In many of these cases, 
KC apoptotic responses can be blocked 
by overexpression of apoptosis inhibi-
tors such as Bcl-2 and the IAP pro-
tein Survivin (Grossman et al., 2001). 
Upregulation of endogenous apoptotic 
inhibitors of the Bcl-2 and IAP families 
can promote KC survival in vivo and, as 
discussed below, may play important 
roles in carcinogenesis.
Evidence for Keratinocyte Apoptosis In 
Vivo
Sunburn cells. After acute UVB expo-
sure, scattered dyskeratotic KCs with 
condensed or absent nuclei and eosin-
ophilic cytoplasm (termed ‘sunburn 
cells’) can be seen in mouse skin by 
routine hematoxylin and eosin staining. 
Sunburn cells represent KCs undergo-
ing UVB-induced apoptosis and can be 
identified by in situ end labeling with 
terminal deoxynucleotidyl transfer-
ase (TUNEL technique) (Brash, 1997) 
and staining for activated caspase-3 
(Pentland et al., 2004). Sunburn-cell 
incidence typically peaks 24 hours after 
irradiation, then gradually declines over 
several days (Okamoto et al., 1999). 
Using p53-deficient mice, Ziegler et al. 
(1994) demonstrated that sunburn-cell 
formation requires p53. Expression of 
p53 is upregulated in UVB-treated KCs 
through increased protein stability (Liu 
et al., 1994). One transcriptional tar-
get of p53 is galectin-7 (PIG1), which 
parallels p53 stabilization and is highly 
expressed in sunburn cells (Bernerd et 
al., 1999). Overexpression of galectin-7 
in KCs is sufficient to cause apoptosis 
(Bernerd et al., 1999), through caspase 
activation and cytochrome c release 
(Kuwabara et al., 2002). In addition 
to upregulation of p53, UVB-irradi-
ated skin reveals upregulation of Bax 
and downregulation of Bcl-2 (Lee et 
al., 2003). Signaling through the Fas 
death receptor, which rapidly clusters 
following UVB exposure (Bang et al., 
2003), appears to be involved in sun-
burn-cell formation, which is reduced 
in mice deficient in Fas-L (Hill et al., 
1999). In addition, UVB-induced DNA 
damage is also necessary for sunburn-
cell formation, which requires genera-
tion of cyclobutane pyrimidine dimers 
(Ley and Applegate, 1985) in actively 
transcribed genes (Brash et al., 2001). 
Activation of these apoptotic pathways 
by UVB is balanced by activation of 
the E2F1 transcription factor, which 
is upregulated in response to DNA 
damage and promotes DNA repair. 
Transgenic overexpression of E2F1 is 
associated with reduced UVB-induced 
apoptosis in vivo (Berton et al., 2005), 
and E2F1-deficient mice demonstrate 
enhanced susceptibility to sunburn-cell 
formation (Wikonkal et al., 2003).
Apoptotic versus non-apoptotic cell 
death. Although it is generally accept-
ed that sunburn cells represent KCs 
induced to undergo apoptosis in vivo, 
some controversy exists over whether 
elimination of normal KCs in epider-
mal development occurs by spontane-
ous apoptosis or a ‘non-apoptotic’ form 
of cell death. The term ‘apoptosis’ was 
originally used to describe particular 
morphologic events observed in iso-
lated cells of normal tissues and tumors 
(Kerr et al., 1972). Whereas cells under-
going pathologic cell death (necrosis) 
are characterized by organelle swell-
ing and membrane rupture, with leak-
age of cell contents, that generates 
marked inflammation, apoptotic cells, 
by contrast, exhibit cellular condensa-
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to be other granular layer proteins 
involved in stratum corneum forma-
tion. The availability of an inducible 
caspase-14 knockdown or knockout 
mouse would be particularly useful in 
further discriminating the role of cas-
pase-14 from the roles of other caspas-
es in epidermal differentiation and KC 
apoptotic responses.
Apoptosis in Epidermal Homeostasis and 
Stratum Corneum Formation
A multigenic developmental program. 
Although the rates of KC proliferation 
and apoptosis are high in newborn skin 
and decrease with aging (Haake et al., 
1998), they remain matched throughout 
life to maintain epidermal homeostasis. 
Epidermal development is coordinated 
at each stage through sequential expres-
sion of multiple gene programs, as typi-
fied by the keratins (Fuchs, 1993) and 
summarized in Figure 4. In the basal 
layer, epidermal stem cells give rise to 
transient amplifying cells that prolifer-
ate and express keratins 5 and 14. In the 
spinous and granular layers, differenti-
ating KCs terminate expression of ker-
atins 5 and 14 and initiate expression 
of keratins 1 and 10. Two key signal-
ing molecules activated by the MAPK 
cascade are expressed in the upper 
epidermis and appear to trigger the dif-
ferentiation program: apoptosis signal-
regulating kinase-1 (ASK1) and dual 
leucine zipper-bearing kinase (DLK). 
Introduction of activated ASK1 (Sayama 
et al., 2001) or DLK (Robitaille et al., 
2005) in KCs is sufficient to induce 
morphologic changes and expression 
of the differentiation markers transglu-
taminase-1, loricrin, and involucrin. 
In the transitional layer, expression of 
caspase-14 correlates with the distinct 
changes seen in KC morphology. The 
'apoptotic gene program' — unlike 
those associated with proliferation and 
differentiation — is not localized to 
one region but is manifest throughout 
the epithelium (Figure 4). For example, 
basal KCs are protected from apoptosis 
by expression of Bcl-2, which is absent 
from suprabasal KCs (Hockenbery et al., 
1991), and a gradient of Bak expression 
increases from lower to upper layers to 
promote cell death (Krajewski et al., 
1996). Similarly, expression of the p53 
inhibitor MDM2  increases from the 
basal to the suprabasal layer (Ganguli 
et al., 2000). A more complex view 
of KC apoptotic control in vivo was 
revealed in experiments by Nickoloff 
and colleagues (Nickoloff et al., 2002), 
who fractionated normal epidermal 
compartments by density gradient and 
assessed each for expression of various 
apoptotic components. They found that 
although some death receptors (TNF 
receptor 1, death receptor 4) and cas-
pase-8 were expressed more intensely 
in lower-layer fractions, other mole-
cules (death receptor 5, Decoy R2, cas-
pase-14, Bcl-xL) were more prevalent in 
upper-layer fractions.
Similarly, apoptotic control is criti-
cal for fetal epidermal development 
in establishing the final architecture 
of the epidermis and its appendages. 
Polakowska et al. (1994) showed that 
transglutaminases in fetal periderm 
localize to cells with DNA fragmenta-
tion that lack Bcl-2. The bone morpho-
genetic protein signaling pathways are 
important promoters of apoptosis dur-
ing skin morphogenesis, as overexpres-
sion of the bone morphogenetic protein 
antagonist noggin is associated with 
retardation of KC differentiation and 
with downregulation of death recep-
tors and the KC differentiation mark-
ers loricrin and involucrin (Sharov et 
al., 2003). Although we have limited 
understanding of all the factors control-
ling these gene expression programs 
and directing KC transition to succes-
sive stages, these experiments and oth-
ers noted above suggest that at least 
some components of the KC apoptotic 
machinery are involved in normal fetal 
and adult epidermal development.
Even though apoptotic morphol-
ogy is not apparent until the transi-
tional layer, it has been suggested 
that downregulation of β1 integrins 
associated with KC exit from the basal 
compartment represents 'anoikis in 
vivo'and signals the initiation of apop-
tosis (Ishida-Yamamoto et al., 1999). 
Although it is unclear at what point KCs 
are irreversibly committed to under-
go apoptosis, the integration of the 
apoptotic machinery into the KC devel-
opmental program must be highly 
regulated so that apoptosis does not 
precede differentiation. Premature 
apoptosis is prevented by expression 
and activation of survival factors includ-
ing Bcl-2, Akt, and NF-κB, as discussed 
above. Equally important, the timing of 
differentiation must be controlled so 
that apoptosis is not delayed. Is KC dif-
ferentiation inextricably linked to cell 
death? Although forced expression of 
ASK1 or DLK, as noted above, induces 
differentiation but not apoptosis, many 
stimuli that induce KC differentiation 
in vitro do lead to apoptosis (Benassi et 
al., 1997). Cultured KCs that become 
senescent, however, are resistant to 
apoptosis (Qin et al., 2002). Although 
KC differentiation and apoptosis have 
been dissociated in vivo with caspase 
inhibitors as noted above and animal 
models as discussed below, it would 
also be interesting to examine the con-
verse scenario in which differentiation 
(but not apoptosis) was blocked. The 
availability of genetic mouse models 
deficient in ASK1 or DLK, and one 
deficient in caspase-14 as suggested 
above, would be particularly useful 
in distinguishing the relationship and 
individual roles of differentiation and 
apoptosis in epidermal development.
Altered epidermal development in 
animal models. The importance of 
apoptosis in epidermal development 
and homeostasis has been substan-
tiated in several genetically modi-
fied mouse models. Many apoptosis-
impaired mouse strains have been con-
structed by knockout of various apop-
totic effector and regulatory molecules. 
Unfortunately, most of these were not 
constructed as conditional knockouts or 
with skin-specific gene deletions. Given 
the critical role of apoptosis in embry-
onic development, it is not surprising 
that many of these animals (particu-
larly those deficient in caspases) exhibit 
prenatal or perinatal lethality that pre-
cludes assessment of skin phenotype. 
By contrast, most mouse models based 
on KC-specific transgenic expression or 
deletion of apoptotic regulators have 
proven viable and amenable for study.
Mice harboring a Bcl-2 transgene 
driven by the suprabasal keratin 1 pro-
moter (HK1.bcl-2) display increased 
resistance to sunburn-cell formation 
(Rodriguez-Villanueva et al., 1998). 
Although their skin appears clinically 
normal, HK1.bcl-2 mice have areas of 
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tion and nuclear fragmentation and are 
rapidly cleared by phagocytosis with-
out inflammation. Apoptosis is increas-
ingly defined, however, at a biochemi-
cal rather than a cellular level by events 
such as DNA fragmentation and cas-
pase activation, considered hallmarks 
of apoptosis. Failure in other systems 
to demonstrate one or more of these 
molecular features in the absence of 
necrosis has led to the suggestion that 
some cells may be eliminated in vivo 
by non-apoptotic forms of cell death 
(Leist and Jaattela, 2001).
Many morphologic features of 
apoptosis have been observed in the 
transitional layer of the epidermis. 
Transitional KCs lose their keratohyalin 
granules and develop condensation of 
cytoplasm and nuclei, which contain 
fragmented DNA (Ishida-Yamamoto et 
al., 1998). There has been some difficul-
ty, however, in detecting specific mark-
ers for apoptosis in the upper layers of 
the epidermis. For example, TUNEL 
staining often reveals surprisingly few 
positive cells in normal skin (Haake et 
al., 1998). Studies in other tissues and 
tumors have found similarly low rates 
of spontaneous apoptosis (Staunton and 
Gaffney, 1995). One possible explana-
tion for the rare detection of apoptotic 
cells in vivo is that they are efficiently 
removed from tissues. Although rapid 
clearance by phagocytic cells (presum-
ably Langerhans cells, although cells 
capable of removing apoptotic cells 
from epidermis have not been defined) 
may explain the decrease in the num-
ber of TUNEL-positive cells in basal and 
spinous layers, we know that most KCs 
undergoing spontaneous cell death in 
epidermis are not removed but persist 
to form the structural component of the 
stratum corneum. Therefore, failure to 
identify apoptotic KCs in the upper epi-
dermis may reflect a technical limitation 
of the TUNEL technique in the granular 
layer and sub-stratum corneum.
Detection of caspase activation in 
situ initially appeared to be similarly 
problematic, as early studies identi-
fied precursor forms of most caspas-
es, but not their activated fragments. 
Subsequent experiments demonstrat-
ed cytochrome c release and multiple 
caspase activation in reconstituted 
human epidermis (Allombert-Blaise 
et al., 2003) and caspase-3 activity in 
human epidermal cytosolic extracts 
(Weil et al., 1999), although other 
investigators failed to detect caspase-
3 activation in mouse skin (Lippens et 
al., 2000). Recent studies by Nickoloff 
et al. (BJ Nickoloff, B Bodner, L Sitailo, 
MF Denning, and V Chartuvedi, 2005, 
J Invest Dermatol 124:A59) using 
human epidermal equivalents dem-
onstrated activation of both initiator 
caspase-8 and -9 and effector cas-
pase-3 during terminal differentiation. 
Moreover, addition of cell-permeable 
caspase inhibitors to a developing 
reconstituted epidermis resulted in 
decreased filaggrin staining and reten-
tion of KC nuclei in the upper layers 
(Weil et al., 1999) and prevented stra-
tum corneum formation (Allombert-
Blaise et al., 2003). Thus caspase 
activation appears to be required for 
normal epidermal development.
Caspase-14, a keratinocyte-specific 
caspase. Several groups reported 
in 1998 a newly identified caspase 
— designated caspase-14 — that, 
unlike other known caspases that are 
expressed ubiquitously, is found only 
in skin (Van de Craen et al., 1998). 
Caspase-14 expression is detectable 
in the basal layer and dramatically 
increases in the granular layer, with 
both the 28-kilodalton proenzyme 
and cleavage fragments of 17 and 11 
kilodaltons visualized in extracts from 
whole human epidermis and stratum 
corneum (Eckhart et al., 2000b). In 
mouse skin, a 35-kilodalton precur-
sor is cleaved into 20- and 18.5-kilo-
dalton peptides (Lippens et al., 2000). 
Complementary experiments with 
HaCaT cells and normal human KCs 
in vitro demonstrated that caspase-
14 was only expressed and processed 
under culture conditions mimicking 
terminal differentiation and could not 
be induced by death receptor signal-
ing or UVB treatment (Lippens et al., 
2000). Splice variants encoding trun-
cated caspase-14 molecules have 
been found in both human (Eckhart et 
al., 2000a) and mouse (Kuechle et al., 
2001) skin, but their particular func-
tion is unknown. N-terminal sequenc-
ing of caspase-14 cleavage fragments 
suggests that, unlike processing of 
other caspases, which undergo either 
autolytic or caspase-mediated cleav-
age at aspartate residues, processing of 
caspase-14 occurs by a novel caspase-
independent proteolytic mechanism  
(Chien et al., 2002). The protease cal-
pain is co-expressed with caspase-14 
in the granular layer and may mediate 
its processing, as Kuechle and col-
leagues (AJ Chien, A Pirrone, and MK 
Kuechle, 2005, J Invest Dermatol 124:
A67) recently reported that caspase-14 
processing can be blocked in organo-
typic skin cultures by a calpain inhibi-
tor. The targets of activated caspase-14 
have not been defined but are likely 
Figure 4. Genetic programs in epidermal development. Apoptosis maintains epidermal homeostasis, 
balancing cell death in the granular layer with proliferation in the lower layers. The proliferative gene 
program is characterized by a restricted pattern of keratin gene expression. The differentiation program 
directs changes in expression of keratin genes, master differentiation genes (apoptosis signal-regulating 
kinase-1 (ASK1), dual leucine zipper-bearing kinase (DLK)), and  genes involved in stratum corneum 
formation. The apoptotic gene program is manifest throughout the epithelium, maintaining gradients of 
antiapoptotic and proapoptotic factors that regulate the timing of apoptosis in epidermal development.
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focal epidermal hyperplasia character-
ized by increased proliferative activ-
ity and aberrant expression of keratin 
6. Mice deficient in Bcl-2 also have 
normal skin (Veis et al., 1993) (with 
the exception of premature hair gray-
ing due to the importance of Bcl-2 for 
melanocyte survival) (Nishimura et 
al., 2005), but sunburn-cell responses 
in these mice have not been reported. 
Spontaneous formation of apoptotic 
cells was seen in unirradiated mice 
with KC-specific deletion of Bcl-xL, 
and these mice demonstrated a further 
increase in susceptibility to sunburn-
cell formation after UVB exposure 
(Umeda et al., 2003). Mice transgenic 
for the p53 inhibitor MDM2 (K14-
MDM2) driven by the basal keratin 
14 promoter exhibit a more dramatic 
phenotype, developing scaly skin in 
the first week of life (Ganguli et al., 
2000). Histologic examination of skin 
in K14-MDM2 mice revealed an epi-
dermis with increased thickness and 
KC-cell number, and the presence of 
nucleated cells in the upper compart-
ments. Detection of keratins 5 and 14 
in suprabasal KCs provided further evi-
dence that the differentiation program 
was also altered in K14-MDM2 mice. 
Mice with KC-specific deletion of the 
Akt inhibitor PTEN (K5-PTEN-flox/flox) 
develop epidermal hyperplasia and 
hyperkeratosis (Suzuki et al., 2003). 
These examples appear to validate the 
role of apoptosis in maintaining epider-
mal homeostasis, controlling differenti-
ation, and mediating UVB responses.
There are, however, additional 
mouse models in which an altered 
apoptotic state is not associated with 
perturbation in epidermal develop-
ment. For example, mice transgenic 
for Bcl-2 under the control of a keratin 
14 promoter have a normal-appearing 
epidermis despite increased apoptotic 
resistance in KCs (Rossiter et al., 2001). 
Similarly, mice with keratin 14-driven 
transgenes expressing antiapoptotic 
Bcl-xL (Pena et al., 1997) and Survivin 
(Grossman et al., 2001), as well as those 
deficient in p53 (Grossman et al., 2001; 
Ziegler et al., 1994), exhibit increased 
KC resistance to UVB-induced apop-
tosis yet normal KC differentiation and 
epidermal maturation. Thus, whereas in 
some cases, as noted above, manipula-
tion of the KC apoptotic program can 
significantly affect KC differentiation 
and epidermal development, in many 
of these mouse models apoptotic dys-
regulation (as reflected by altered sun-
burn-cell formation) does not. Some of 
the variation in these effects may relate 
to differences in the levels of transgene 
expression (that is, promoter effects), as 
reflected by differences seen between 
hemizygous and homozygous K14-
MDM2 mice (Ganguli et al., 2000). 
Another factor potentially affected 
by the particular promoter used is the 
resulting KC compartment targeted, as 
promoters active only in stem or basal 
cells tend to affect skin phenotype 
differently from those active in the 
suprabasal cell layers.
Dysfunctional apoptosis in skin disease
Diseases of increased keratinocyte 
apoptosis. As sunburn cells represent 
the histologic manifestation of iso-
lated KC apoptosis, clinical sunburn 
is the classic example of generalized 
UVB-induced apoptosis. Although 
UVB activates both death receptor and 
mitochondrial apoptotic pathways in 
KCs, several skin diseases have been 
ascribed predominantly to excessive 
death receptor activation, as reviewed 
previously in the Journal by Wehrli et 
al. (2000). Death receptor signaling 
is triggered in KCs by cytokines and 
direct contact with intraepidermal lym-
phocytes, via TNF and Fas receptors, 
respectively. These interactions likely 
play a key role in the pathogenesis of 
toxic epidermal necrolysis and cutane-
ous graft-versus-host disease. Apoptotic 
KCs are also a feature of cutane-
ous viral infections, alopecia areata, 
Kindler’s syndrome, incontinentia pig-
menti, lichen planus, and other lichen-
oid reactions, but the role of excessive 
apoptosis in these disorders is poorly 
understood and hence will not be dis-
cussed further. Although apoptosis-
based therapies have had limited use 
in patients, many have been demon-
strated in animal models or are in clini-
cal development (Table 1).
Table 1. Summary of skin diseases with dysregulated apoptosis
Skin disease Apoptosis Mechanisms Potential therapies
Sunburn Increased UVB-induced apoptosis
Cytokine secretion
—
Toxic epidermal necrolysis Increased Upregulation of Fas ligand
TNF production
Antibody blocking 
(anti-Fas, anti-TNF, 
intravenous Ig1)
Graft-versus-host disease Increased Fas-mediated lymphocyte-directed 
killing
TNF production
Antibody blocking 
(anti-Fas, anti-TNF)
Psoriasis Decreased Keratinocyte senescence
Increased TNF (paradoxical)
IL-15
Survivin, Bcl-xL expression
TNF inhibitors1
Anti-IL-15 antibody
Skin cancer (basal-cell and squamous-cell 
carcinoma)
Decreased p53 mutation or deletion
Decreased death receptors
Stat3 activation
Survivin, Bcl-2, Bcl-xL
Introduction of p53 
TRAIL
Bortezomib
Stat3 decoy
1Currently used in these patients. Abbreviations: TNF, tumor necrosis factor; TRAIL, TNF-related apoptosis-inducing ligand.
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In toxic epidermal necrolysis, a 
drug-induced hypersensitivity reaction 
causes massive KC apoptosis, result-
ing in widespread epidermal detach-
ment. French and colleagues demon-
strated that Fas-L, which is sequestered 
by intermediate filaments in normal 
KCs (Viard-Leveugle et al., 2003), is 
upregulated and expressed extracellu-
larly in involved skin and capable of 
mediating cytotoxicity against normal 
Fas-expressing KCs (Viard et al., 1998). 
Soluble Fas-L may also be secreted 
by mononuclear cells in patients with 
toxic epidermal necrolysis (Abe et al., 
2003) and is found in lesional blister 
fluid (Nassif et al., 2004). Antibody 
blocking of the Fas–Fas-L interaction 
appears protective in this disease and 
represents the rationale for treatment 
with intravenous Ig, a therapy that has 
been used with remarkable success 
in adults (Prins et al., 2003) and chil-
dren (Tristani-Firouzi et al., 2002). The 
potential involvement of additional 
molecules such as TNF, which is also 
found in lesional blister fluid (Nassif et 
al., 2004), may explain why efficacy of 
Ig therapy does not correlate directly 
with concentration of Fas/Fas-L-block-
ing antibodies (Prins et al., 2003).
In graft-versus-host disease, a com-
mon complication of allogeneic bone 
marrow transplantation, damage to the 
skin and other tissues is largely medi-
ated by activated cytotoxic T lympho-
cytes. The term ‘satellite-cell necrosis,’ 
referring to degenerating KCs associ-
ated with adjacent lymphocytes, is 
a misnomer, as the KCs are apoptotic 
rather than necrotic. These lympho-
cytes express Fas-L and induce KC 
apoptosis through direct cell contact 
and secretion of cytokines, primarily 
TNF-α. Animal models have revealed 
that both Fas-L and TNF-α are impor-
tant in the pathogenesis of graft-ver-
sus-host disease. When donor T cells 
are derived from mice deficient in Fas-
L, there is reduced mortality and skin 
disease (Baker et al., 1996). Although 
antibodies against TNF-α similarly con-
fer protection, targeting of both Fas-L 
and TNF-α is required for complete 
abrogation of graft-versus-host disease 
(Hattori et al., 1998). TNF-α appears to 
be more important than Fas-L, howev-
er, in mediating beneficial graft-versus-
leukemia reactions that often accom-
pany graft-versus-host disease (Tsukada 
et al., 1999).
Diseases of decreased keratinocyte 
apoptosis. Whereas diseases asso-
ciated with increased KC apoptosis 
tend to be acute, those associated 
with decreased apoptosis tend to be 
chronic. In fact, most skin diseases or 
cutaneous lesions characterized by 
epidermal hyperplasia or hyperkerato-
sis likely involve decreased KC apop-
tosis. Psoriasis and skin cancer are 
the most notable examples and will 
be discussed here. A common feature 
of these two diseases, along with seb-
orrheic and actinic keratosis, verru-
cae, and lichen simplex chronicus, is 
expression of Survivin (Bowen et al., 
2004). Unlike other known IAPs and 
most apoptotic inhibitors, Survivin 
is generally not expressed in normal 
skin. Interestingly, we found in psoria-
sis and lichen simplex chronicus that 
Survivin expression is localized to the 
upper third of the epidermis, whereas 
keratoses, basal-cell carcinoma, and 
squamous-cell carcinoma (SCC) reveal 
staining in all epidermal layers (Bowen 
et al., 2004).
In psoriasis, there is decreased 
spontaneous KC apoptosis in lesional 
skin (Laporte et al., 2000), which cor-
relates with decreased levels of cas-
pase-14 (Lippens et al., 2000). KCs in 
psoriatic plaques exhibit a phenotype 
reminiscent of that of senescent KCs, 
characterized by resistance to apop-
tosis compared with normal KCs and 
lack of p53 activation (Qin et al., 2002; 
Wrone-Smith et al., 1997). Multiple 
factors likely contribute to increased 
resistance of KCs to apoptosis in this 
disease. First, it is possible that psoriatic 
KCs are resistant to TNF signaling, given 
that TNF-α is paradoxically elevated in 
psoriatic skin. For unknown reasons, 
maintenance of disease is dependent 
on TNF-α, and this represents the basis 
for multiple novel biologic therapies 
targeting this cytokine. Other cytokines 
involved in psoriasis include IL-15, a 
potent inhibitor of KC apoptosis in vitro 
that is upregulated in psoriatic skin 
(Ruckert et al., 2000) and has proven 
to be a viable target in animal models 
(Villadsen et al., 2003). In addition to 
Survivin, multiple studies consistent-
ly demonstrated increased levels of 
Bcl-xL, which is downregulated in 
response to topical vitamin D3 treat-
ment (Fukuya et al., 2002).
Non-melanoma skin cancers dem-
onstrate multiple examples of apoptot-
ic dysregulation in which proapoptotic 
regulatory molecules are reduced or 
antiapoptotic molecules are overex-
pressed. Mutation or deletion of p53 
occurs in many skin cancers and is dis-
cussed in detail below. Basal-cell car-
cinomas tend to have reduced expres-
sion of Bax (Tomkova et al., 1998) and 
increased expression of Bcl-2 (Morales-
Ducret et al., 1995), and Bcl-xL is over-
expressed in SCC (Wrone-Smith et al., 
1999). A relatively higher apoptotic 
rate in basal-cell carcinoma (Staunton 
and Gaffney, 1995), however, may 
account for the slow growth of clini-
cal basal-cell carcinoma lesions. The 
presence of Survivin in pre-malignant 
lesions (Bowen et al., 2004) suggests 
that its expression represents an early 
step in KC transformation. In SCC, 
expression of Bcl-2 (Hantschmann 
and Kurzl, 2000), Bcl-xL (Matsumoto 
et al., 2001), and Survivin (Lo Muzio 
et al., 2001) is associated with meta-
stasis or poor prognosis. Many stud-
ies have shown that targeting these 
molecules in KC cell lines results in 
apoptosis (Grossman et al., 1999). 
TNF-related apoptosis-inducing ligand 
(TRAIL) (Stander and Schwarz, 2005), 
its receptor (Bachmann et al., 2001), 
and Fas-L (Bachmann et al., 2001) are 
reduced in actinic keratosis and SCC. 
Progression of SCC is also associated 
with constitutive activation of KC sur-
vival signaling pathways. In malignant 
KCs, signaling through EGFR activates 
the transcription factor Stat3 (Quadros 
et al., 2004), which drives expression 
of multiple antiapoptotic molecules, 
including Bcl-xL and Mcl-1 (Buettner 
et al., 2002). Activation of the EGFR–
Stat3 axis is associated with SCC pro-
gression (Bowman et al., 2000; Rubin 
Grandis et al., 1998), and activation 
of the Akt/NF-κB pathway is com-
monly seen in SCC (Nakayama et al., 
2001). The role of some of these regu-
lators and pathways in promoting skin 
cancer development in experimental 
models is discussed below.
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Apoptosis as a Cancer Defense 
Mechanism
Apoptosis in the skin acts as a defense 
against cancer at two levels. First, 
apoptotic elimination of KCs in the 
upper epidermis results in removal of 
cells that may have acquired pre-malig-
nant genetic alterations. Second, apop-
tosis may be directly induced in KCs 
exposed to carcinogenic stimuli, usual-
ly as part of the DNA damage response. 
This mechanism would be particularly 
important in eliminating KC stem cells 
that are long-lived and not destined for 
apoptotic turnover.
Role of p53. As noted above, KC apop-
totic responses in vivo are generally 
dependent on p53, which is activated 
and regulated in cells by multiple fac-
tors (Vogelstein and Kinzler, 1992). 
Levels of p53 are potentially sup-
pressed in normal KCs by a number 
of regulators, including PTEN (which 
inhibits Akt), products of the p38 MAPK 
pathway, and the Retinoblastoma pro-
tein; p53 is activated by ATM-medi-
ated phosphorylation, and p19ARF 
protects it from degradation by inhibit-
ing MDM2. p53 delays cell cycle pro-
gression (in G1 by inducing the Cdk2/
cyclin E inhibitor p21Cip1, and in G2 
through the Cdc25 inhibitor 14-3-3σ), 
presumably until DNA damage can be 
repaired (Harris and Levine, 2005), or 
promotes apoptosis through transcrip-
tional and non-transcriptional mecha-
nisms. Transcription of proapoptotic 
regulators of the mitochondrial path-
ways (Bax, Noxa, Puma, Apaf-1) and 
death receptor pathways (Fas, death 
receptors 4 and 5) may be activated 
by p53, and that of antiapoptotic mol-
ecules (Bcl-2, Bcl-xL, Survivin) may 
be repressed (Yu and Zhang, 2005). In 
addition, p53 can translocate to the 
mitochondria and interfere with Bcl-2 
family proteins, resulting in cytochrome 
c release (Chipuk et al., 2004).
Exposure of KCs to UVB does not 
always result in apoptosis but rath-
er may cause mutations in the p53 
gene that lead to apoptosis resistance. 
Compromise of p53 function through 
UVB-induced mutation conceiv-
ably undermines the apoptosis-based 
defense mechanism, allowing p53-
mutant KCs to survive repeated cycles 
of UVB exposure. Further impairment of 
p53 and other genes through additional 
UVB-induced mutations may then lead 
to even greater resistance to apoptosis 
and acquisition of pre-malignant chang-
es. Consistent with this scenario, p53-
deficient mice are highly susceptible to 
UVB-induced SCC (Li et al., 1998).
Clonal model of squamous-cell carci-
noma. Given the proapoptotic func-
tion of p53 in UVB-treated KCs, it is not 
surprising that the p53 gene is disabled 
by mutation in most SCCs (Brash et al., 
1991). Commonly, these mutations 
are C→T and CC→TT transitions, also 
known as 'UVB signature' mutations 
(Kress et al., 1992). Most SCCs exhibit 
loss of heterozygosity with respect to 
p53 and have point mutations on the 
remaining allele (Basset-Seguin et al., 
1994). With respect to SCC precursors, 
p53 mutations are found in most actinic 
keratoses (Ziegler et al., 1994). Different 
p53 mutations occur in separate kerato-
ses, but all cells within a single precur-
sor lesion tend to have the same muta-
tion (Ziegler et al., 1994). Mutations in 
p53 can be detected in KCs from clini-
cally normal sun-exposed skin with a 
frequency of up to 1% (Nakazawa et 
al., 1994), and clonal patches of p53-
mutated KCs are larger and more fre-
quent in sun-exposed skin (Jonason et 
al., 1996). In mouse models, the same 
p53 mutations are present in clones and 
subsequent SCC (Kramata et al., 2005). 
Moreover, development of these p53-
mutated clones correlates with tumor 
induction in a mouse model (Rebel et 
al., 2001). These findings substantiate 
a clonal basis for SCC and suggest that 
p53 mutation is an early event in UVB-
induced skin carcinogenesis (Figure 5a).
This clonal hypothesis suggests a 
defined role for p53-mediated apop-
tosis in suppressing the development 
and progression of SCC. At the earli-
est stage, apoptosis would be predicted 
to act selectively on normal but not on 
p53-mutant cells, promoting forma-
tion of a p53+/– clone. During continu-
ous UVB exposure, there is subsequent 
clonal expansion in which mutant cells 
extend beyond the borders of their origi-
nal stem-cell compartment (Zhang et al., 
p53 mutation Apoptosis Mutant clone Papilloma SCC
p53 mutation Apoptosis Mutant clone Papilloma SCC
UVB
a  Normal apoptosis sensitivity   
b Increased apoptotic resistance   
UVB UVB
UVB UVB UVB
Figure 5. Schematic model depicting multiple roles of apoptosis in the various stages of UVB-induced 
skin carcinogenesis. Under normal conditions (a), UVB causes a p53 mutation (black cell) that confers 
apoptosis resistance. However, continued UVB exposure also induces apoptosis in neighboring 
keratinocytes (white cells, thick arrow), facilitating expansion of the p53-mutant clone. Ultimately, large 
clones develop into papillomas (thick arrow), and some papillomas that acquire additional mutations 
will convert to SCC. Under conditions of increased apoptosis resistance (b), as seen in the skin of 
K14-Survivin mice, creation of initial p53-mutant cells is enhanced (increased number of black cells, 
thick arrow) but fewer neighboring keratinocytes undergo apoptosis; this results in the formation of 
smaller but more numerous p53-mutant clones. This reduced clonal expansion leads to formation of 
fewer papillomas, but the increased apoptosis resistance selects for mutations that facilitate malignant 
conversion to squamous-cell carcinoma (SCC) (thick arrow).
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2001). Large clones either regress or ulti-
mately form a papilloma. Transition from 
papilloma to SCC (malignant conversion) 
involves new mutations (Yuspa, 1998), 
and thus apoptosis would be expected to 
exert a negative or protective influence 
at this stage as well (Figure 5a).
Role of Apoptosis in Animal Models of 
Skin Cancer
Antitumorigenic effects of apoptosis. 
A number of animal models support 
the notion that KC apoptosis suppress-
es tumor formation. It is worth noting, 
however, that in most cases neither 
forced expression of apoptotic resis-
tance factors nor deletion of proapop-
totic molecules is purely oncogenic 
(that is, sufficient to cause skin tumors). 
In these models, a mutagenic stimulus 
such as UVB or a chemical carcinogen 
like 9,10-dimethyl-1,2-benzanthracene 
is also needed. For example, whereas 
p53-deficient animals spontaneously 
develop lymphoma and sarcoma, topi-
cal application of 9,10-dimethyl-1,2-
benzanthracene or chronic UVB is 
required for development of cutaneous 
SCC. As is noted above, these animals 
are more prone to UVB-induced SCC 
(Li et al., 1998). Similarly, K14-MDM2 
mice are more susceptible to chemical 
carcinogenesis (Ganguli et al., 2000). 
Mice transgenic for Bcl-xL also dem-
onstrate enhancement of chemical-
induced tumors as well as an increased 
rate of malignant conversion (Pena et 
al., 1998). Genetic alterations in prima-
ry KC survival pathways also predispose 
to cutaneous tumorigenesis. For exam-
ple, the K5-PTEN-flox/flox mice with 
constitutive Akt activation demonstrate 
accelerated tumor onset with chemical 
treatment (Suzuki et al., 2003). 
Treatment with an EGFR inhibitor 
reduces UVB-induced skin tumorigen-
esis (El-Abaseri et al., 2005). Similarly, 
mice deficient in Stat3 are resistant to 
chemical carcinogenesis (Chan et al., 
2004). The HK1.bcl-2 mice demonstrate 
increased susceptibility to chemical car-
cinogenesis (Rodriguez-Villanueva et 
al., 1998). Taken together, these studies 
support a role for apoptosis resistance 
in the development of SCC.
Paradoxical role of apoptosis in car-
cinogenesis. Other mouse models 
engineered to modulate KC apoptosis, 
however, demonstrate unexpected phe-
notypes. Although p53-deficient mice 
are more susceptible to UVB-induced 
tumor formation (Li et al., 1998), para-
doxical findings have emerged from 
studies in mice with reduced (but not 
absent) p53. Chemical carcinogenesis 
studies with mice on a p53+/– back-
ground demonstrated increased 
resistance to tumor formation com-
pared with that in wild-type animals 
(Greenhalgh et al., 1996; Kemp et al., 
1993), although the rate of malignant 
conversion was enhanced (Kemp et al., 
1993). These results, contrasting with 
those in K14-MDM2 mice (Ganguli et 
al., 2000), may reflect multiple mecha-
nisms of p53 regulation and targets of 
MDM2. Consistent with these findings, 
Chaturvedi et al. (2005) reported that 
RNA interference-mediated reduction 
of p53 levels in KCs enhances rather 
than inhibits UVB-induced apoptosis.
Although NF-κB is a survival sig-
nal in KCs, as is noted above, and is 
activated in many tumor types, NF-
κB blockade in the skin, surprisingly, 
promotes KC transformation and SCC 
formation (Dajee et al., 2003). Mice 
transgenic for IκB demonstrate 
increased KC apoptosis but also sponta-
neously develop SCC (van Hogerlinden 
et al., 1999). Similarly, increased KC 
apoptosis in mice deficient in Cox-1 is 
not associated with reduction in UVB-
induced tumors (Pentland et al., 2004). 
In addition, several mouse models with 
increased KC apoptosis resistance are 
less susceptible to skin carcinogenesis. 
For example, K14-Bcl-2 (Rossiter et 
al., 2001) and K14-Survivin (Allen et 
al., 2003; Zhang et al., 2005) mice are 
resistant to sunburn-cell formation but 
yield reduced numbers of chemical- 
and UVB-induced papillomas. These 
mice have normal skin, whereas others 
with increased susceptibility to tumori-
genesis have hyperkeratosis (Ganguli et 
al., 2000; Rodriguez-Villanueva et al., 
1998) — although some mice with such 
susceptibility, for example, Bcl-xL trans-
genic mice, do not have skin hyper-
keratosis (Pena et al., 1998). Thus, the 
lack of correlation between apoptosis 
resistance and susceptibility to tumor 
formation and malignant conversion 
in these studies suggests that apoptosis 
may play a more complex role in con-
trolling skin tumorigenesis than previ-
ously expected.
Apoptosis promotes early tumorigenic 
events. It is curious that agents required 
for experimental induction of skin 
cancer — namely 9,10-dimethyl-1,
2-benzanthracene and UVB — are also 
potent apoptotic stimuli in KCs (Allen 
et al., 2003). This may merely reflect 
the need to induce mutations in p53 
and other genes but, alternatively, may 
indicate a requirement for apoptosis in 
some early steps of cutaneous carcino-
genesis. Perturbations of KC apoptotic 
balance might then potentially result 
in multiple (and unpredictable) effects 
on carcinogenesis. Zhang et al. (2001) 
examined p53-mutant clones in multi-
stage UVB carcinogenesis and found 
that, when UVB exposure was discon-
tinued, clones ceased expanding and 
regressed; this suggested that UVB was 
driving clonal expansion by a physio-
logic mechanism other than creation of 
additional mutations. It seemed plau-
sible that this dependence of clonal 
expansion on sustained UVB exposure 
might reflect a requirement for apop-
tosis in adjacent KCs, providing space 
to accommodate the expanding clone 
(Figure 5a). Indeed, formation of iso-
lated ‘imprisoned’ clones, character-
ized by increased cell number without 
increased area, was observed follow-
ing withdrawal of UVB during clonal 
expansion (Zhang et al., 2001).
To test this possibility, we examined 
p53-mutant clones in apoptosis-defec-
tive K14-Survivin mice at multiple steps 
during UVB carcinogenesis (Zhang et 
al., 2005). We found that, under condi-
tions of reduced apoptosis, formation of 
small p53-mutant clones was enhanced, 
consistent with a role for apoptosis in 
suppressing new mutations by remov-
ing mutant cells. Formation of medium 
and large clones, on the other hand, was 
impaired, suggesting that inhibition of 
apoptosis impairs clonal expansion; and 
tumor yield was reduced. Papillomas that 
formed under these conditions, however, 
demonstrated an increased tendency 
for malignant conversion. These results 
support a revised model, with apoptosis 
restraining stages that involve new muta-
tions — initiation and malignant conver-
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sion — but promoting clonal expansion 
of existing mutant cells and develop-
ment of papillomas (Figure 5b). These 
opposing roles of apoptosis in restraining 
and promoting early steps in skin car-
cinogenesis may explain the divergent 
phenotypes observed in the animal 
models of dysregulated apoptosis des-
cribed above.
Future Challenges and Directions
In the 30 years since apoptosis was first 
described in the skin, we have acquired 
a vast understanding of the biochemis-
try and molecular controls involved in 
programmed cell death and have come 
to appreciate the role of KC apopto-
sis in epidermal development (Figure 
4) and various skin diseases (Figure 3, 
Table 1). Future challenges include 
unraveling the details of how differen-
tiation and apoptosis are controlled in 
epidermal development, and further 
understanding the factors that shift 
apoptotic balance in KCs in response 
to different stimuli. Findings from 
experiments with KCs in vitro need to 
be validated in vivo. New animal mod-
els of apoptotic dysfunction based on 
inducible or regulated KC gene expres-
sion are needed, as well as models that 
better recapitulate the morpho logy 
of human skin. The clinical implica-
tions of this new knowledge will be 
development of new apoptosis-based 
therapeutics, directed toward protec-
tion of KCs from apoptosis in those 
diseases characterized by excessive 
KC cell death, or enhancement of KC 
apoptosis in diseases in which KC cell 
death is impaired (Table 1). Although a 
wide range of inflammatory and hyper-
keratotic diseases might be amenable 
to apoptosis-based therapies, there 
appears to be greatest interest in devel-
oping agents for cancer. Several have 
recently been tested in SCC, including 
the proteasome inhibitor bortezomib 
(Velcade) (Fribley et al., 2004), an ade-
novirus expressing wild-type p53 (Yoo 
et al., 2004) and a Stat3 decoy (Xi et al., 
2005) to shift the apoptotic balance in 
malignant KCs. The multiple roles of 
apoptosis in multi-step skin carcinogen-
esis (Figure 5) suggest that apoptosis-
modulating therapies may have varied 
and unanticipated effects on formation 
of actinic keratoses and SCC.
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